Literature DB >> 16265891

Malaria in the pregnant woman.

P E Duffy1, M Fried.   

Abstract

Women become more susceptible to Plasmodium falciparum malaria during pregnancy, and the risk of disease and death is high for both the mother and her fetus. In low transmission areas, women of all parities are at risk for severe syndromes like cerebral malaria, and maternal and fetal mortality are high. In high transmission areas, where women are most susceptible during their first pregnancies, severe syndromes like cerebral malaria are uncommon, but severe maternal anemia and low birth weight are frequent sequelae and account for an enormous loss of life. P. falciparum-infected red cells sequester in the intervillous space of the placenta, where they adhere to chondroitin sulfate A but not to receptors like CD36 that commonly support adhesion of parasites infecting nonpregnant hosts. Poor pregnancy outcomes due to malaria are related to the macrophage-rich infiltrates and pro-inflammatory cytokines such as tumor necrosis factor-alpha that accumulate in the intervillous space. Women who acquire antibodies against chrondroitin sulfate A (CSA)-binding parasites are less likely to have placental malaria, and are more likely to deliver healthy babies. In areas of stable transmission, women acquire antibodies against CSA-binding parasites over successive pregnancies, explaining the high susceptibility to malaria during first pregnancy, and suggesting that a vaccine to prevent pregnancy malaria should target placental parasites. Prevention and treatment of malaria are essential components of antenatal care in endemic areas, but require special considerations during pregnancy. Recrudescence after drug treatment is more common during pregnancy, and the spread of drug-resistant parasites has eroded the usefulness of the few drugs known to be safe for the woman and her fetus. Determining the safety and effectiveness of newer antimalarials in pregnant women is an urgent priority. A vaccine that prevents pregnancy malaria due to P. falciparum could be delivered before first pregnancy, and would have an enormous impact on mother-child health in tropical areas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16265891     DOI: 10.1007/3-540-29088-5_7

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  24 in total

1.  Seasonal Variation in the Epidemiology of Asymptomatic Plasmodium falciparum Infections across Two Catchment Areas in Bongo District, Ghana.

Authors:  Kathryn E Tiedje; Abraham R Oduro; Godfred Agongo; Thomas Anyorigiya; Daniel Azongo; Timothy Awine; Anita Ghansah; Mercedes Pascual; Kwadwo A Koram; Karen P Day
Journal:  Am J Trop Med Hyg       Date:  2017-07       Impact factor: 2.345

2.  Comparative Study on Antenatal and Perinatal Outcome of Vivax and Falciparum Malaria in a Tertiary Care Hospital of Kolkata, India.

Authors:  Mousumi Datta; Jhuma Biswas; Shyamal Dasgupta; Kaushik Banerjee; Subhendu Choudhury; Sandip Kumar Sengupta; Prakash Das
Journal:  J Clin Diagn Res       Date:  2017-01-01

3.  Placental malaria in Colombia: histopathologic findings in Plasmodium vivax and P. falciparum infections.

Authors:  Jaime Carmona-Fonseca; Eliana Arango; Amanda Maestre
Journal:  Am J Trop Med Hyg       Date:  2013-04-01       Impact factor: 2.345

4.  Fucosylated chondroitin sulfate inhibits Plasmodium falciparum cytoadhesion and merozoite invasion.

Authors:  Marcele F Bastos; Letusa Albrecht; Eliene O Kozlowski; Stefanie C P Lopes; Yara C Blanco; Bianca C Carlos; Catarina Castiñeiras; Cristina P Vicente; Claudio C Werneck; Gerhard Wunderlich; Marcelo U Ferreira; Claudio R F Marinho; Paulo A S Mourão; Mauro S G Pavão; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

5.  The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.

Authors:  Inès Vigan-Womas; Adjimon Lokossou; Micheline Guillotte; Alexandre Juillerat; Graham Bentley; André Garcia; Odile Mercereau-Puijalon; Florence Migot-Nabias
Journal:  Malar J       Date:  2010-10-05       Impact factor: 2.979

6.  Iron deficiency anemia: focus on infectious diseases in lesser developed countries.

Authors:  Julia G Shaw; Jennifer F Friedman
Journal:  Anemia       Date:  2011-05-15

7.  Malaria at parturition in Nigeria: current status and delivery outcome.

Authors:  Olugbenga A Mokuolu; Catherine O Falade; Adeola A Orogade; Henrietta U Okafor; Olanrewaju T Adedoyin; Tagbo A Oguonu; Hannah O Dada-Adegbola; O A Oguntayo; Samuel K Ernest; Davidson H Hamer; Michael V Callahan
Journal:  Infect Dis Obstet Gynecol       Date:  2009-07-20

Review 8.  Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications.

Authors:  J Alexandra Rowe; Antoine Claessens; Ruth A Corrigan; Mònica Arman
Journal:  Expert Rev Mol Med       Date:  2009-05-26       Impact factor: 5.600

9.  Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring.

Authors:  Whitney E Harrington; Robert Morrison; Michal Fried; Patrick E Duffy
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Association between immunoglobulin GM and KM genotypes and placental malaria in HIV-1 negative and positive women in western Kenya.

Authors:  Nnaemeka C Iriemenam; Janardan P Pandey; John Williamson; Anna J Blackstock; Ajay Yesupriya; Aryan M Namboodiri; Keith M Rocca; Anna Maria van Eijk; John Ayisi; Juliana Oteino; Renu B Lal; Feiko O ter Kuile; Richard Steketee; Bernard Nahlen; Laurence Slutsker; Ya Ping Shi
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.